HealthDay - TUESDAY, June 28 (HealthDay News) -- Cancer patients taking the drugs sunitinib and sorafenib respond to the flu vaccine, which suggests that the drugs don't cause as much damage to the immune system as previously believed, researchers say.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.